Novartis India Outperforms Sector Amid Broader Market Rebound and Small-Cap Gains

Novartis India has shown significant activity today, with the stock rising by 8.95% on March 21, 2025. This performance has allowed it to outperform its sector by 5.29%. Over the past four days, Novartis India has experienced a consecutive gain, accumulating a total return of 12.58%. The stock reached an intraday high of Rs 841, marking a 6.66% increase during the trading session.
In terms of moving averages, Novartis India is currently above its 5-day, 20-day, and 50-day moving averages, although it remains below the 100-day and 200-day moving averages. The stock also boasts a high dividend yield of 3.17% at its current price.

In the broader market context, the Sensex has rebounded sharply after a negative opening, currently trading at 76,978.81, reflecting a 0.83% increase. Small-cap stocks are leading the market, with the BSE Small Cap index gaining 2.15%. Despite Novartis India's recent gains, its longer-term performance shows a decline of 15.64% over the past year, contrasting with the Sensex's 5.97% increase during the same period.